X-linked agammaglobulinemia (XLA)
Overview
X-linked agammaglobulinemia (XLA), or Bruton's agammaglobulinemia, is a rare inherited immunodeficiency caused by mutations in the BTK gene, preventing B-cell maturation and resulting in very low antibody levels. Primarily affecting males, it leads to recurrent bacterial infections, commonly starting at 6-9 months old, requiring lifelong immunoglobulin replacement therapy.
Symptoms
Recurrent Infections: Frequent, persistent, or severe infections of the ears (otitis media), sinuses (sinusitis), nose (rhinitis), and lungs (pneumonia, bronchitis).
Respiratory Infections: Bacterial pneumonia is common and, when it occurs in infants, is a strong indicator of XLA.
Skin and Eye Infections: Abscesses, pyoderma, and conjunctivitis (pink eye).
Gastrointestinal Issues: Chronic diarrhea, often due to a lack of IgA antibodies.
Serious Infections: Sepsis (blood poisoning), meningitis (spinal cord infection), and septic arthritis.
Physical Findings: Small or absent tonsils and lymph nodes due to low B-cell count.
Causes
BTK Gene Mutation: The mutation prevents the production of functional BTK protein, which is crucial for B-cell development.
B-cell Maturation Arrest: Without functional BTK, B-cell development stalls at the pre-B-cell stage in bone marrow, preventing the formation of mature B lymphocytes.
Antibody Deficiency: Because mature B cells (which turn into plasma cells) are absent, the body cannot produce adequate antibodies (immunoglobulins).
Inheritance Pattern: Because the mutation is on the X chromosome, males (XY) with the mutated gene will have the disease. Females (XX) are usually carriers if they have one affected X chromosome.
Diagnosis
Medical History: Recurring bacterial infections, particularly respiratory and ear infections, typically appearing after 6–9 months when maternal antibodies wane.
Laboratory Tests: Serum Immunoglobulins: Very low levels of IgG, IgA, and IgM.
Flow Cytometry: Almost complete absence of CD19+ or CD20+ B cells.
Antibody Response: Failure to produce antibodies to vaccinations.
Genetic Testing: Identification of a mutation in the \(BTK\) (Bruton's tyrosine kinase) gene.
Treatment
Immunoglobulin Replacement Therapy (IGRT): This is the mainstay of treatment, providing antibodies (IgG) that the body cannot produce.
Intravenous (IVIG): Usually administered every 3–4 weeks, according to Medscape.
Subcutaneous (SCIG): Often administered weekly at home, as described in StatPearls and PMC.
Goal: Maintain IgG trough levels of \(500–800 \text{ mg/dL}\), note Medscape.
Antibiotic Therapy: Prompt and often aggressive use of antibiotics is necessary for treating infections. Prophylactic (preventive) antibiotics may be used for chronic, persistent infections, particularly to prevent sinusitis and pneumonia,
Avoidance of Live Vaccines: Individuals with XLA must avoid live viral/bacterial vaccines, such as MMR, oral polio, rotavirus, and nasal influenza .
Monitoring and Care: Regular check-ups with an immunologist, often every 6–12 months, are required to monitor for complications.
Type of Doctor Department : A pediatric or adult immunologist
.jpg)
Comments
Post a Comment